What are the possible side effects of LITFULO? LITFULO may cause serious side effects, including: See What is the most important information I should know about LITFULO? The most common side effects of LITFULO include: headache diarrhea acne rash hives inflamed hair pores (folliculitis) fever eczema
Read the full prescribing information, including the BOXED WARNING, for FDA-approved LITFULO, an Rx treatment for severe alopecia areata in people (ages 12).
Summary Basis of Decision for Litfulo Health Canada approves updates to Mifegymiso prescribing information: Ultrasound no longer mandatory [ ]
LITFULO (ritlecitinib) Clinical Pharmacology 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action LITFULO is a kinase inhibitor. Download Prescribing Information
The prescribing information for Litfulo includes a Boxed Warning describing increased risks of serious infection, mortality, malignancy
Prescribing Information. New York, NY: Pfizer labs.; May 2024. Nirmatrelvir Litfulo. Prescribing Information. New York, NY: Pfizer labs Inc.; June
See full prescribing information for LITFULO. LITFULO (ritlecitinib) capsules, for oral use. Initial U.S. Approval: 2024. WARNING: SERIOUS INFECTIONS
Litfulo (ritlecitinib) – In September 2024, Pfizer announced the prescribing information. (8). The Pfizer-BioNTech COVID-19 Vaccine
Please see full Prescribing Information, including BOXED WARNING, and Medication Guide for LITFULO, and full Prescribing Information, including BOXED
Comments